Skip to main content
. 2015 Mar;15(3):193–205. doi: 10.2174/1566524015666150330142807

Table 3.

Affinities of compounds for recombinant NMDA receptors [116, 117].

Agonist and co-agonist GluN2A GluN2B GluN2C GluN2D GluN3A GluN3B
EC50 (µM)
Glutamate 7.7 2.3 1 0.39
Glycine 1.2 0.38 0.32 0.12 57 95
Competitive antagonists GluN2A GluN2B GluN2C GluN2D GluN3A GluN3B
Ki (µM)
(R)-AP5 0.28 0.46 1.6 3.7
UBP141 14 19 4.2 2.8
Channel blockers GluN2A GluN2B GluN2C GluN2D GluN3A GluN3B
IC50 (µM)
(+)MK801 0.015 0.0099 0.024 0.038
Ketamine 5.4 5.1 1.2 2.9
Phencyclidine 0.82 0.16 0.16 0.22
Noncompetitive antagonists GluN2A GluN2B GluN2C GluN2D GluN3A GluN3B
IC50 (µM)
Ifenprodil 39 0.15 29 76
Ro25-6981 52 0.009
Allosteric potentiators GluN2A GluN2B GluN2C GluN2D GluN3A GluN3B
EC50 (µM)
CIQ NE NE 2.8 3.0

NE, no detectable effect.